Assertio Holdings Inc
NASDAQ:ASRT
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.754
1.75
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ASRT stock under the Base Case scenario is 1.562 USD. Compared to the current market price of 0.979 USD, Assertio Holdings Inc is Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Assertio Holdings Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ASRT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Assertio Holdings Inc
Balance Sheet Decomposition
Assertio Holdings Inc
Current Assets | 181.2m |
Cash & Short-Term Investments | 88.6m |
Receivables | 44.9m |
Other Current Assets | 47.6m |
Non-Current Assets | 94.8m |
PP&E | 1.8m |
Intangibles | 92.4m |
Other Non-Current Assets | 698k |
Current Liabilities | 90.1m |
Accounts Payable | 13.2m |
Accrued Liabilities | 74m |
Other Current Liabilities | 3m |
Non-Current Liabilities | 55.4m |
Long-Term Debt | 38.8m |
Other Non-Current Liabilities | 16.5m |
Earnings Waterfall
Assertio Holdings Inc
Revenue
|
125.8m
USD
|
Cost of Revenue
|
-37.3m
USD
|
Gross Profit
|
88.4m
USD
|
Operating Expenses
|
-104.9m
USD
|
Operating Income
|
-16.5m
USD
|
Other Expenses
|
-52m
USD
|
Net Income
|
-68.5m
USD
|
Free Cash Flow Analysis
Assertio Holdings Inc
USD | |
Free Cash Flow | USD |
ASRT Profitability Score
Profitability Due Diligence
Assertio Holdings Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Assertio Holdings Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
ASRT Solvency Score
Solvency Due Diligence
Assertio Holdings Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Assertio Holdings Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ASRT Price Targets Summary
Assertio Holdings Inc
According to Wall Street analysts, the average 1-year price target for ASRT is 3.091 USD with a low forecast of 2.172 USD and a high forecast of 4.2 USD.
Dividends
Current shareholder yield for ASRT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ASRT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. The company is headquartered in Lake Forest, Illinois and currently employs 19 full-time employees. The firm's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor (diclofenac potassium) Liquid filled capsules. The firm has other commercially available products, which include OXAYDO (oxycodone HCI, USP) tablets for oral use only. Assertio and Zyla are the registered trademarks of the Company. INDOCIN products are used for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.
Contact
IPO
Employees
Officers
The intrinsic value of one ASRT stock under the Base Case scenario is 1.562 USD.
Compared to the current market price of 0.979 USD, Assertio Holdings Inc is Undervalued by 37%.